user

Anti-infliximab antibodies in RA patients treated with infliximab.

被引：0
|
作者：
Wolbink, GJ
Lems, WF
Nurmohamed, MT
Vis, M
Voskuyl, AE
Stapel, S
de Groot, E
Tak, PP
Dijkmans, BA
Aarden, L
机构：
[1] Jan Van Breeman Inst, Amsterdam, Netherlands
[2] Slotervaart Hosp, Amsterdam, Netherlands
[3] Vrije Univ Amsterdam, Ctr Med, NL-1081 HV Amsterdam, Netherlands
[4] Sanquin Res, Amsterdam, Netherlands
[5] UVA, Amsterdam Med Ctr, Amsterdam, Netherlands
来源：
ARTHRITIS AND RHEUMATISM | 2004年 / 50卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：S187 / S187
页数：1
相关论文
共 50 条
  • [41] TROUGH INFLIXIMAB LEVELS AND ANTI-INFLIXIMAB ANTIBODIES IN SPONDYLOARTHRITIS PATIENTS ON TREATMENT WITH LOW DOSE INFLIXIMAB: A SINGLE CENTRE CROSS-SECTIONAL STUDY
    Patil, A.
    Upadhyaya, S. K.
    Dawar, R.
    Vaishnav, B.
    Dadhaniya, N.
    Gupta, S. J.
    Handa, R.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2017, 76 : 1292 - 1292
  • [42] Improvement in hemoglobin in patients with rheumatoid arthritis treated with infliximab.
    Doyle, M. K.
    Rahman, M. U.
    Han, J.
    Baker, D.
    Giles, J. T.
    Bingham, C. O., III
    Bathon, J. M.
    [J]. ARTHRITIS AND RHEUMATISM, 2006, 54 (09): : S235 - S235
  • [43] Anti-infliximab antibodies in patients with rheumatoid arthritis who require higher doses of infliximab to achieve or maintain a clinical response
    Haraoui, B
    Cameron, L
    Ouellet, M
    White, B
    [J]. JOURNAL OF RHEUMATOLOGY, 2006, 33 (01) : 31 - 36
  • [44] Anti-infliximab antibodies are eliminated more rapidly in vivo than non-immune antibodies in the presence of infliximab
    Rojas, J
    Rutkoski, T
    Vennarini, J
    Jang, H
    Wagner, CL
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2003, 62 : 175 - 175
  • [45] InfliximabDevelopment of anti-infliximab antibodies, rash and fever: case report
    [J]. Reactions Weekly, 2019, 1775 (1) : 259 - 259
  • [46] Infliximab and anti-infliximab antibody levels in Crohn's disease
    Hendy, Philip
    [J]. FRONTLINE GASTROENTEROLOGY, 2014, 5 (04) : 227 - 228
  • [47] Therapeutic drug monitoring countering the effect of anti-infliximab antibodies
    Hooijberg, Femke
    Wolbink, Gertjan
    [J]. LANCET RHEUMATOLOGY, 2024, 6 (04): : e193 - e194
  • [48] Clinical Laboratory Validation of a Functional Assay for Monitoring Infliximab Biological Activity and Neutralizing Anti-infliximab Antibodies
    Delgado, Julio
    Pavlov, Igor
    Kusukawa, Noriko
    Skodack, Lisa
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2013, 108 : S517 - S518
  • [49] Anti-infliximab antibodies and low infliximab levels correlate with drug discontinuation in pediatric inflammatory bowel disease
    Zitomersky, Naamah
    Chi, Lisa
    Liu, Enju
    Bray, Kurtis R.
    Papamichael, Konstantinos
    Cheifetz, Adam S.
    Snapper, Scott B.
    Bousvaros, Athos
    Silvester, Jocelyn A.
    [J]. JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION, 2024, 78 (02): : 261 - 271
  • [50] Standardization of the homogeneous mobility shift assay protocol for evaluation of anti-infliximab antibodies. Application of the method to Crohn's disease patients treated with infliximab
    Hernandez-Breijo, B.
    Chaparro, M.
    Cano-Martinez, D.
    Guerra, I.
    Iborra, M.
    Cabriada, J. L.
    Bujanda, L.
    Taxonera, C.
    Garcia-Sanchez, V.
    Marin-Jimenez, I.
    Barreiro-de Acosta, M.
    Vera, I.
    Martin-Arranz, M. D.
    Mesonero, F.
    Sempere, L.
    Gomollon, F.
    Hinojosa, J.
    Gisbert, J. P.
    Guijarro, L. G.
    [J]. BIOCHEMICAL PHARMACOLOGY, 2016, 122 : 33 - 41
12345